ArticleBioactive materials2021

HIF1α epigenetically repressed macrophages via CRISPR/Cas9-EZH2 system for enhanced cancer immunotherapy.

Yan Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.